APA (7th ed.) Citation

Y, S., S, K., M, S., K, I., E, K., T, S., . . . Y, N. (2022). Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo. Annals of nuclear medicine, 36(3), 319. https://doi.org/10.1007/s12149-021-01706-4

Chicago Style (17th ed.) Citation

Y, Shimizu, et al. "Development of a Novel Indium-111 Radiolabeled Mogamulizumab Targeting CCR4 for Imaging Adult T-cell Leukemia/lymphoma in Vivo." Annals of Nuclear Medicine 36, no. 3 (2022): 319. https://doi.org/10.1007/s12149-021-01706-4.

MLA (9th ed.) Citation

Y, Shimizu, et al. "Development of a Novel Indium-111 Radiolabeled Mogamulizumab Targeting CCR4 for Imaging Adult T-cell Leukemia/lymphoma in Vivo." Annals of Nuclear Medicine, vol. 36, no. 3, 2022, p. 319, https://doi.org/10.1007/s12149-021-01706-4.